AKT1 (Prognostic Marker for Neuroendocrine Tumors) Antibody

Biorbyt

AKT1 (Prognostic Marker for Neuroendocrine Tumors) Antibody

10

Positive Control: PDGF-treated NIH/3T3 cells. HeLa cell lysates. Human pancreas or cervical carcinoma. Western Blot (1-2ug/ml);Immunohistochemistry (Formalin-fixed) (1-2ug/ml for 30 min at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 10mM Tris with 1mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes); Optimal dilution for a specific application should be determined. IHC, WB

Western Blot, ImmunoHistoChemistry

Research Use Only

Monoclonal

AKT1/2552

1.0 mg/ml

Unconjugated

AKT1

AKT serine/threonine kinase 1

AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA, RAC-alpha serine/threonine-protein kinase, AKT1m, PKB alpha, RAC-PK-alpha, protein kinase B alpha, proto-oncogene c-Akt, rac protein kinase alpha, serine-threonine protein kinase, v-akt murine thymoma viral oncogene homolog 1, v-akt murine thymoma viral oncogene-like protein 1

Mouse

IgG2b

RAC-alpha serine/threonine-protein kinase

AKT1 (Prognostic Marker for Neuroendocrine Tumors) Antibody

Human

-20°C,2°C to 8°C

12352203